Found: 59
Select item for more details and to access through your institution.
Phase 1b Study of Trebananib Plus Paclitaxel and Trastuzumab in Patients With HER2-Positive Locally Recurrent or Metastatic Breast Cancer.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Palbociclib-Induced Thrombotic Microangiopathy in Metastatic Breast Cancer Patient Surviving for 18 Years: Case Report and Review of the Literature.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Antiangiogenic Therapy in Patients With HER2-Positive Metastatic Breast Cancer: A Case Series.
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45974-w
- By:
- Publication type:
- Article
Le cancer du sein de la femme âgée (hors situation métastatique).
- Published in:
- Oncologie (Tech Science Press), 2011, v. 13, n. 10/11, p. 755, doi. 10.1007/s10269-011-2079-8
- By:
- Publication type:
- Article
Bevacizumab for Newly Diagnosed Ovarian Cancers: Best Candidates Among High-Risk Disease Patients (ICON-7).
- Published in:
- JNCI Cancer Spectrum, 2020, v. 4, n. 3, p. 1, doi. 10.1093/jncics/pkaa026
- By:
- Publication type:
- Article
HER2-Positive Metastatic Breast Cancer: Available Treatments and Current Developments.
- Published in:
- Cancers, 2023, v. 15, n. 6, p. 1738, doi. 10.3390/cancers15061738
- By:
- Publication type:
- Article
The Increasing Prognostic and Predictive Roles of the Tumor Primary Chemosensitivity Assessed by CA-125 Elimination Rate Constant K (KELIM) in Ovarian Cancer: A Narrative Review.
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 98, doi. 10.3390/cancers14010098
- By:
- Publication type:
- Article
Impact of the First Wave of the COVID-19 Pandemic on the Lyon University Hospital Cancer Institute (IC-HCL).
- Published in:
- Cancers, 2022, v. 14, n. 1, p. 29, doi. 10.3390/cancers14010029
- By:
- Publication type:
- Article
Her2 Expression in Circulating Tumor Cells Is Associated with Poor Outcomes in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Cancers, 2021, v. 13, n. 23, p. 6014, doi. 10.3390/cancers13236014
- By:
- Publication type:
- Article
COVID-19 Presentation and Outcomes among Cancer Patients: A Matched Case-Control Study.
- Published in:
- Cancers, 2021, v. 13, n. 21, p. 5283, doi. 10.3390/cancers13215283
- By:
- Publication type:
- Article
Using Breast Cancer Gene Expression Signatures in Clinical Practice: Unsolved Issues, Ongoing Trials and Future Perspectives.
- Published in:
- Cancers, 2021, v. 13, n. 19, p. 4840, doi. 10.3390/cancers13194840
- By:
- Publication type:
- Article
Methods and Designs of Modern Breast Cancer Confirmatory Trials.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2757, doi. 10.3390/cancers13112757
- By:
- Publication type:
- Article
Measuring Quality of Life Using Patient-Reported Outcomes in Real-World Metastatic Breast Cancer Patients: The Need for a Standardized Approach.
- Published in:
- Cancers, 2021, v. 13, n. 10, p. 2308, doi. 10.3390/cancers13102308
- By:
- Publication type:
- Article
A Systematic Review of the Use of Circulating Cell-Free DNA Dynamics to Monitor Response to Treatment in Metastatic Breast Cancer Patients.
- Published in:
- Cancers, 2021, v. 13, n. 8, p. 1811, doi. 10.3390/cancers13081811
- By:
- Publication type:
- Article
Ovarian Cancer-Associated Mesothelial Cells: Transdifferentiation to Minions of Cancer and Orchestrate Developing Peritoneal Dissemination.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1352, doi. 10.3390/cancers13061352
- By:
- Publication type:
- Article
Front-Line Maintenance Therapy in Advanced Ovarian Cancer—Current Advances and Perspectives.
- Published in:
- Cancers, 2020, v. 12, n. 9, p. 2414, doi. 10.3390/cancers12092414
- By:
- Publication type:
- Article
Revisiting dosing regimen using PK/PD modeling: the MODEL1 phase I/II trial of docetaxel plus epirubicin in metastatic breast cancer patients.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 156, n. 2, p. 331, doi. 10.1007/s10549-016-3760-9
- By:
- Publication type:
- Article
Hypersensitivity to oxaliplatin: clinical features and risk factors.
- Published in:
- BMC Pharmacology & Toxicology, 2014, v. 15, n. 1, p. 1, doi. 10.1186/2050-6511-15-1
- By:
- Publication type:
- Article
Adherence to oral anticancer chemotherapy: What influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 1, doi. 10.1186/s13104-015-1231-8
- By:
- Publication type:
- Article
Adherence to oral anticancer chemotherapy: What influences patients’ over or non‑adherence? Analysis of the OCTO study through quantitative–qualitative methods.
- Published in:
- BMC Research Notes, 2015, v. 8, n. 1, p. 291, doi. 10.1186/s13104-015-1231-8
- By:
- Publication type:
- Article
Lhermitte sign and urinary retention.
- Published in:
- Cancer (0008543X), 2002, v. 94, n. 9, p. 2434, doi. 10.1002/cncr.10500
- By:
- Publication type:
- Article
Improving Cancer Patient Care with Combined Medication Error Reviews and Morbidity and Mortality Conferences.
- Published in:
- Chemotherapy (0009-3157), 2014, v. 59, n. 5, p. 330, doi. 10.1159/000358190
- By:
- Publication type:
- Article
Olaparib First-Line Maintenance Monotherapy in BRCA-Mutated Epithelial Ovarian Cancer: Descriptive Analysis of the First French Real-World Data Study.
- Published in:
- Drugs - Real World Outcomes, 2023, v. 10, n. 2, p. 207, doi. 10.1007/s40801-022-00349-9
- By:
- Publication type:
- Article
First-Line Treatments for Poor-Prognosis Metastatic Renal Cell Carcinoma: Experts' Prescribing Practices and Systematic Literature Review.
- Published in:
- Clinical Drug Investigation, 2016, v. 36, n. 5, p. 389, doi. 10.1007/s40261-016-0384-0
- By:
- Publication type:
- Article
Prognostic value of modeled PSA clearance on biochemical relapse free survival after radical prostatectomy.
- Published in:
- Prostate, 2009, v. 69, n. 12, p. 1325, doi. 10.1002/pros.20978
- By:
- Publication type:
- Article
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 5, p. 413, doi. 10.1007/s00280-023-04520-z
- By:
- Publication type:
- Article
Clinical results of the EVESOR trial, a multiparameter phase I trial of everolimus and sorafenib combination in solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2023, v. 91, n. 5, p. 361, doi. 10.1007/s00280-023-04508-9
- By:
- Publication type:
- Article
Optimization of G-CSF dosing schedule in patients treated with eribulin: a modeling approach.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Validation of an online tool for early prediction of the failure-risk in gestational trophoblastic neoplasia patients treated with methotrexate.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Over-adherence to capecitabine: a potential safety issue in breast and colorectal cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS)
- Published in:
- 2014
- By:
- Publication type:
- Journal Article
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand-foot syndrome (HFS).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2014, v. 73, n. 2, p. 287, doi. 10.1007/s00280-013-2352-1
- By:
- Publication type:
- Article
Dose adaptation of capecitabine based on individual prediction of limiting toxicity grade: evaluation by clinical trial simulation.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 447, doi. 10.1007/s00280-011-1714-9
- By:
- Publication type:
- Article
Tobacco use and related behaviors among staff and students in a university hospital: A large cross-sectional survey.
- Published in:
- Tobacco Prevention & Cessation, 2021, v. 7, p. 1, doi. 10.18332/tpc/137670
- By:
- Publication type:
- Article
Population pharmacokinetics of doxorubicin, etoposide and ifosfamide in small cell lung cancer patients: results of a multicentre study.
- Published in:
- British Journal of Clinical Pharmacology, 2000, v. 50, n. 4, p. 315, doi. 10.1046/j.1365-2125.2000.00269.x
- By:
- Publication type:
- Article
Revisiting Dosing Regimen Using Pharmacokinetic/Pharmacodynamic Mathematical Modeling: Densification and Intensification of Combination Cancer Therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Pharmacodynamic Models for Discrete Data.
- Published in:
- Clinical Pharmacokinetics, 2012, v. 51, n. 12, p. 767, doi. 10.1007/s40262-012-0014-9
- By:
- Publication type:
- Article
Exposure-Effect Population Model of Inolimomab, a Monoclonal Antibody Administered in First-Line Treatment for Acute Graft-Versus-Host Disease.
- Published in:
- Clinical Pharmacokinetics, 2007, v. 46, n. 5, p. 417, doi. 10.2165/00003088-200746050-00004
- By:
- Publication type:
- Article
Low probability of disease cure in advanced ovarian carcinomas before the PARP inhibitor era.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
- Published in:
- Targeted Oncology, 2013, v. 8, n. 4, p. 243, doi. 10.1007/s11523-012-0242-9
- By:
- Publication type:
- Article
COVID ou cancer : choix tragique et dilemme éthique.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Covid ou cancer : choix tragique et dilemme éthique.
- Published in:
- Bulletin Infirmier du Cancer, 2020, v. 20, n. 2, p. 61, doi. 10.1684/bic.2020.111
- By:
- Publication type:
- Article
Changes in the Use of Comprehensive Geriatric Assessment in Clinical Trials for Older Patients with Cancer over Time.
- Published in:
- Oncologist, 2019, v. 24, n. 8, p. 1089, doi. 10.1634/theoncologist.2018-0493
- By:
- Publication type:
- Article
Current Targeted Therapies in Breast Cancer: Clinical Applications in the Elderly Woman.
- Published in:
- Oncologist, 2011, v. 16, n. 8, p. 1144, doi. 10.1634/theoncologist.2011-0028
- By:
- Publication type:
- Article
Quantitative evaluation of the combination between cytotoxic drug and efflux transporter inhibitors based on a tumour growth inhibition model.
- Published in:
- Fundamental & Clinical Pharmacology, 2014, v. 28, n. 2, p. 161, doi. 10.1111/fcp.12005
- By:
- Publication type:
- Article
A template model for studying anticancer drug efflux transporter inhibitors in vitro.
- Published in:
- Fundamental & Clinical Pharmacology, 2013, v. 27, n. 5, p. 544, doi. 10.1111/j.1472-8206.2012.01054.x
- By:
- Publication type:
- Article
Impact of Age on Poly(ADP-Ribose) Polymerase Inhibitor (PARPi)-Induced Lymphopenia: A Scoping Review of the Literature and Internal Analysis of a Retrospective Database.
- Published in:
- Drugs & Aging, 2023, v. 40, n. 5, p. 397, doi. 10.1007/s40266-023-01023-7
- By:
- Publication type:
- Article
Author Correction: Bevacizumab, olaparib, and durvalumab in patients with relapsed ovarian cancer: a phase II clinical trial from the GINECO group.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice